James De Voss

Title: James De Voss: Innovator in Protease-Binding Compounds

Introduction

James De Voss is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the development of protease-binding compounds. His work has implications for the detection and inhibition of retroviral proteases, which are crucial in the fight against HIV.

Latest Patents

James De Voss holds a patent for "Protease-binding compounds and methods of use." This patent describes non-peptide, protease-binding compounds that are useful in the detection, labeling, and inhibition of retroviral proteases. Specifically, aryl piperidinyl derivatives and other structurally related compounds have been identified as effective in binding to HIV-1 and HIV-2 proteases. He has 1 patent to his name.

Career Highlights

James De Voss is affiliated with the University of California, where he continues to engage in innovative research. His work has contributed to advancements in the understanding of protease functions and their role in viral infections.

Collaborations

Throughout his career, James has collaborated with esteemed colleagues such as Paul R Ortiz De Montellano and Irwin D Kuntz. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

James De Voss is a prominent figure in the field of protease research, with a focus on developing compounds that can aid in the detection and treatment of retroviral infections. His contributions are vital to ongoing efforts in biomedical research and innovation.